HLA-DRβ, -DQα, and -DQβ restriction fragment length polymorphisms in multiple sclerosis
- 1 May 1989
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 23 (1) , 46-54
- https://doi.org/10.1002/jnr.490230107
Abstract
Restriction fragment length polymorphism (RFLP) studies were performed on DNA from unrelated Caucasian patients with multiple sclerosis (MS) using cDNA probes to the HLA class II genes DRβ, DQα, and DQβ. In a study of 34 patients and 34 controls who were not matched for DR type, we found that the DQβ allele‐specific RFLP or allogenotype, termed DQβlb, which corresponds at the molecular level to the DQwl serotype, is preferentially associated with MS. A significant disease association with DR2 was demonstrated by serology but this was not confirmed using DR2/Dw2‐specific RFLPs. We suggest that DQβlb is largely responsible for HLA‐associated susceptibility to MS and that the apparent MS‐DR2 serological association is due to the strong linkage disequilibrium between DR2 and DQβlb. Homozygosity of one of the two allelic bands of the DX α gene, usually termed the DXα lower (DXαL) band (which cross‐hybridizes with the DQα probe), correlated with reduced susceptibility to MS. Similarly a 5.3 kb band identified by the DQα probe in Mspl digests showed a negative correlation with MS. In an analysis of 27 DR2+ controls and 26 DR2+ patients it was found that these individuals all had DR2/Dw2‐specific RFLPs and all had identical DR2/Dw2‐associated DQβ (DQβlb) and DQα (DQαlb) allogenotypes. We detected no polymorphisms of DRβ, DQα, or DQβ genes among the DR2+ MS patients which distinguished them from normals. This suggests that the various HLA class II genes associated with MS are normal and not variant alleles. Because of strong linkage disequilibrium, a particular DRβ allogenotype in Caucasians is characteristically associated with specific DQα and DQβ allogenotypes. However, approximately 20% of all MS patients studied showed anomalous DR‐DQ associations including absence of anticipated allogenotypes or inappropriate allogenotypes. This result suggests that in at least some cases, aberrant DR‐DQ associations may be important in the pathogenesis of MS.Keywords
This publication has 28 references indexed in Scilit:
- Is HLA class II allogenotyping universally applicable?Immunology Today, 1988
- DNA-RFLP analysis and genotyping of HLA-DR and DQ antigensImmunology Today, 1988
- Allogenotypes defined by short DQα and DQβ cDNA probes correlate with and define splits of HLA-DQ serological specificitiesMolecular Immunology, 1987
- HLA-DR restriction-fragment-length polymorphisms in narcolepsyJournal of Neuroscience Research, 1987
- DNA restriction fragment length polymorphism of HLA-DR2: Correlation with HLA-DR2-associated functionsJournal of Neuroimmunology, 1986
- A DR3-related DX? gene polymorphism strongly associates with insulin-dependent diabetes mellitusImmunogenetics, 1986
- Clinical Sub-Groups of Multiple Sclerosis in Relation to HLA: DR Alleles as Possible Markers of Disease ProgressionCanadian Journal of Neurological Sciences, 1985
- Isotypic and allotypic variation of human class II histocompatibility antigen α-chain genesNature, 1984
- Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis.Proceedings of the National Academy of Sciences, 1984
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1983